SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000894579-13-000174
Filing Date
2013-06-17
Accepted
2013-06-17 11:14:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 13 TO SCHEDULE 13D chtpamendment13to13d.htm SC 13D/A 70158
  Complete submission text file 0000894579-13-000174.txt   71441
Mailing Address 4673 CHRISTOPHER PLACE DALLAS TX 75204
Business Address
AUSTIN JOSIAH T (Filed by) CIK: 0000932267 (see all company filings)

Type: SC 13D/A

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81457 | Film No.: 13916005
SIC: 2836 Biological Products, (No Diagnostic Substances)